7 episodes

We aim to help you make better investment decisions by bringing you insights from Natixis Investment Managers’ global expert collective including IML, Loomis Sayles, Mirova, Vaughan Nelson, Flexstone, AEW and others.

Navigating the noise – conversations with the Natixis Investment Managers Expert Collective‪.‬ Natixis Investment Managers Australia

    • Business

We aim to help you make better investment decisions by bringing you insights from Natixis Investment Managers’ global expert collective including IML, Loomis Sayles, Mirova, Vaughan Nelson, Flexstone, AEW and others.

    How will Australia's $3.5 trillion wealth transfer reshape society?

    How will Australia's $3.5 trillion wealth transfer reshape society?

    Around the world, many nations are preparing for the largest ever wealth transfer in history. In Australia, it is estimated around $3.5 trillion in assets will be passed on to future generations by 2050.* 
    So how will this intergenerational wealth transfer impact the Australian economy and society at large?
    Find out in our third and final instalment of  Louise Watson's interview with demographer Simon Kuestenmacher.They discuss:
    How and when wealth will transfer from baby boomers to future generations
    The changing face of retirement
    The impact it will have on the housing market
    The social and ethical considerations of “the bank of mum and dad"
    *Australian Government Productivity Commission 2021 report "Wealth transfers and their economic effects"

    • 19 min
    Why has ResMed rocketed up and is the ride over?

    Why has ResMed rocketed up and is the ride over?

    Shareholders of Resmed have been on a rollercoaster ride in the past year. Late last year, after news of the efficacy of Ozempic and other GLP-1 drugs came to light, the Resmed share price dropped as investors grew concerned about the potential impact on Resmed’s business. But since then it has steadily made up lost ground and is now trading at similar levels.

    - But what has driven the share price appreciation?
    - Has the Ozempic effect hit yet?
    - And does Resmed’s rally have further to go?

    In our latest podcast, IML’s Senior Equity Analyst Bruce Du, gives his perspective.

    • 12 min
    Look beyond market darlings for AI winners

    Look beyond market darlings for AI winners

    AI has easily been the hottest topic in investing this year. While IML Portfolio Manager Daniel Moore is excited about AI’s potential, he sounds a reminder that investing in popular themes is “fraught with danger”. Instead of buying AI-themed market darlings which are now trading at heady valuations, he suggests long-term investors should consider companies which are investing heavily in AI, and are likely to be beneficiaries of it, but haven’t yet seen their share prices appreciate significantly.

    • 16 min
    Australia’s economic future: insights from demographer Simon Kuestenmacher

    Australia’s economic future: insights from demographer Simon Kuestenmacher

    What are the future economic implications of Australia’s heavy reliance on mining, agriculture, tourism and international education?
    In this episode of Navigating the Noise, join Louise Watson, Head of Natixis Investment Managers Australia & New Zealand, for part two of her conversation with demographer Simon Kuestenmacher, this time to discuss Australia’s business model, now and in the future.
    Simon and Louise explore:
    Future implications of Australia’s reliance on key sectors
    Predicted skills shortage and demographic imbalances
    Global comparison of superannuation and pension systems
    Transition to sustainable economy and the impact on mining
    Predicted shifts in economic policies and wealth taxation

    • 17 min
    IML large cap update - March quarter 2024

    IML large cap update - March quarter 2024

    Daniel Moore discusses key stock movements and the future outlook of the large cap fund.

    • 10 min
    IML small cap update - March quarter 2024

    IML small cap update - March quarter 2024

    Find out how the small-mid cap funds performed during the March quarter and why Simon Conn believes many small caps are still undervalued.

    • 10 min

Top Podcasts In Business

Money Rehab with Nicole Lapin
Money News Network
The Ramsey Show
Ramsey Network
REAL AF with Andy Frisella
Andy Frisella #100to0
The Money Mondays
Dan Fleyshman
Young and Profiting with Hala Taha
Hala Taha | YAP Media Network
PBD Podcast
PBD Podcast

You Might Also Like

The Rules of Investing
Livewire Markets
MAGELLAN - In The Know
Magellan Asset Management
Inside the Rope with David Clark
David Clark
Talk Money To Me
Equity Mates Media
Chanticleer
Australian Financial Review
The Call from ausbiz
ausbiz